USP33 and COVID-19: Although the protein level of USP33 is not affected by viral infection, we compared the transcriptomics in severe patients, mild patients, and healthy populations, and found higher levels of USP33 in patients with COVID‐19, which reflected the impact of USP33 on disease severity (Figure S2F, Supporting Information).